The role of hyperthermia in optimizing tumor response to regional therapy

References

• Creech O, Jr, Krementz ET, Ryan RF, Winblad JN. Chemotherapy of cancer: Regional perfusion utilizing an extracorporeal circuit. Ann Surg 1958; 148(4)616–32
   PubMed Web of Science ®Google Scholar
• Crile G. Heat as an adjunct to the teatment of cancer: Experimental studies. Cleveland Clin Quart 1961; 28: 75–89
   PubMedGoogle Scholar
• Takemoto M, Kuroda M, Urano M. The effects of various chemotherapeutic agents with mild hyperthermia on different types of tumours. Int J Hyperthermia 2003; 19: 193–203
   PubMed Web of Science ®Google Scholar
• Mhalaey MSJ, Woodhall B, Knisely WH. Selection of anti-cancer agents for regional brain cancer perfusion. Surg Forum 1960; 10: 774–777
   PubMedGoogle Scholar
• Iliakis G, et al. Evidence for an S-phase checkpoint regulating DNA replication after heat shock: A review. Int J Hyperthermia 2004; 20(2)240–249
   PubMed Web of Science ®Google Scholar
• van der Zee J. Heating the patient: A promising approach?. Ann Oncol 2002; 13(8)173–184
   PubMed Web of Science ®Google Scholar
• Bruns P. Die Heilwirkung des Erysipels auf Geschwulste. Bietr Klin Chir 1887; 3: 443–466
   Google Scholar
• Busch W. Uber den Einfluss welchen Heftigere Erispeln Zuweilen auf Organisierte Neubildungen Ausuben. Verhandl Naurth Preuss Rhein Westphal 1866; 23: 28–30
   Google Scholar
• Coley WB. A Preliminary Note on the treatment of inoperable sarcoma by the toxic product of erysipelas. Post-Graduate 1893; 8: 278–286
   Google Scholar
• Westermark F. Uber die Behandlung des Ulcerirended Cervixcarcinoms. Mittel Konstanter Warme. Zbl Gynak 1898; 00: 1335–1339
   Google Scholar
• Woodhall B, Pickrell KL, Georgiade NG, Mahaley MS, Dukes HT. Effect of hyperthermia on cancer chemotherapy–application to external cancer of head and face structures. Annals Surg 1960; 151: 750–759
   PubMed Web of Science ®Google Scholar
• Cavaliere R, Ciocatto EC, Giovanella BC, Heidelberger C, Johnson RO, Margottini M, Mondovi B, Moricca G, Rossi-Fanelli A. Selective heat sensitivity of cancer cells. Biochemical and clinical studies. Cancer 1967; 20(9)1351–1381
   PubMed Web of Science ®Google Scholar
• Kim JH, Hahn EW, Tokita N. Combination hyperthermia and radiation therapy for cutaneous malignant melanoma. Cancer 1978; 41(6)2143–2148
   PubMed Web of Science ®Google Scholar
• Kim JH, Hahn EW, Tokita N, Nisce LZ. Local tumor hyperthermia in combination with radiation therapy. 1. Malignant cutaneous lesions. Cancer 1977; 40(1)161–169
   PubMed Web of Science ®Google Scholar
• Ghussen F, Kruger I. Technical aspects of isolation extremity perfusion: Experimental studies and clinical experience. J Invest Surg 1989; 2(4)487–496
   PubMedGoogle Scholar
• Ghussen F, et al. The role of regional hyperthermic cytostatic perfusion in the treatment of extremity melanoma. Cancer 1988; 61(4)654–659
   PubMed Web of Science ®Google Scholar
• Ghussen F, Nagel K, Groth W, Muller JM, Stutzer H. A prospective randomized study of regional extremity perfusion in patients with malignant melanoma. Ann Surg 1984; 200(6)764–768
   PubMed Web of Science ®Google Scholar
• Overgaard J, et al. Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology. Lancet 1995; 345(8949)540–543
   PubMed Web of Science ®Google Scholar
• Koops HS, et al. Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: Results of a multicenter randomized phase III trial. European Organization for Research and Treatment of Cancer Malignant Melanoma Cooperative Group Protocol 18832, the World Health Organization Melanoma Program Trial 15, and the North American Perfusion Group Southwest Oncology Group-8593. J Clin Oncol 1998; 6(9)2906–2912
   Web of Science ®Google Scholar
• Eggermont AM, et al. Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience. Ann Surg 1996; 224(6)756–764, discussion 764–765
   PubMed Web of Science ®Google Scholar
• Issels RD, et al. Regional hyperthermia (RHT) improves response and survival when combined with systemic chemotherapy in the management of locally advanced, high grade soft tissue sarcomas (STS) of the extremities, the body wall and the abdomen: A Phase III randomised prospective trial. Proc Am Soc Clin Oncol Annual Meeting Part I 2007; 25(18s)
   Google Scholar
• Issels RD. High-risk soft tissue sarcoma: Clinical trial and hyperthermia combined chemotherapy. Int J Hyperthermia 2006; 22(3)235–239
   PubMed Web of Science ®Google Scholar
• Valdagni R, Amichetti M, Pani G. Radical radiation alone versus radical radiation plus microwave hyperthermia for N3 (TNM-UICC) neck nodes: A prospective randomized clinical trial. Int J Radiat Oncol Biol Phys 1988; 5(1)13–24
   Web of Science ®Google Scholar
• Kitamura K, et al. Prospective randomized study of hyperthermia combined with chemoradiotherapy for esophageal carcinoma. J Surg Oncol 1995; 60(1)55–58
   PubMed Web of Science ®Google Scholar
• Vernon CC, et al. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: Results from five randomized controlled trials. International Collaborative Hyperthermia Group. Int J Radiat Oncol Biol Phys 1996; 35(4)731–744
   PubMed Web of Science ®Google Scholar
• Shchepotin IB, et al. Intensive preoperative radiotherapy with local hyperthermia for the treatment of gastric carcinoma. Surg Oncol 1994; 3(1)37–44
   PubMed Web of Science ®Google Scholar
• Fujimoto S, et al. Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma. Cancer 1999; 85(3)529–534
   PubMed Web of Science ®Google Scholar
• Colombo R, et al. Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma. J Clin Oncol 2003; 21(23)4270–4276
   PubMed Web of Science ®Google Scholar
• Colombo R, et al. Neoadjuvant combined microwave induced local hyperthermia and topical chemotherapy versus chemotherapy alone for superficial bladder cancer. J Urol 1996; 155(4)1227–1232
   PubMed Web of Science ®Google Scholar
• Sneed PK, et al. Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1998; 40(2)287–295
   PubMed Web of Science ®Google Scholar
• van der Zee J, et al. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: A prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 2000; 355(9210)1119–1125
   PubMed Web of Science ®Google Scholar
• Vasanthan A, et al. Regional hyperthermia combined with radiotherapy for uterine cervical cancers: A multi-institutional prospective randomized trial of the international atomic energy agency. Int J Radiat Oncol Biol Phys 2005; 61(1)145–153
   PubMed Web of Science ®Google Scholar
• Maier-Hauff K, et al. Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: Results of a feasibility study on patients with glioblastoma multiforme. J Neurooncol 2007; 81(1)53–60
   PubMed Web of Science ®Google Scholar
• Shea SM, Caulfield JB, Burke JF. Microvascular ultrastructure in thermal injury: A reconsideration of the role of mediators. Microvascular Research 1973; 5: 87–96
   PubMed Web of Science ®Google Scholar
• Song C, et al. Implications of increased tumor blood flow and oxygenation caused by mild temperature hyperthermia in tumor treatment. Int J Hyperthermia 2005; 21(8)761–768
   PubMed Web of Science ®Google Scholar
• Horsman MR. Tissue physiology and the response to heat. Int J Hyperthermia 2006; 22(3)197–203
   PubMed Web of Science ®Google Scholar
• Song CW. Effect of local hyperthermia on blood flow and microenvironment: a review. Cancer Res 1984; 44(10 Suppl)4721s–4730s
   PubMed Web of Science ®Google Scholar
• Overgaard J, Bichel P. The influence of hypoxia and and acidity on the hyperthermic response of malignant cells in vitro. Radiology 1977; 23(2)511–514
   Web of Science ®Google Scholar
• Overgaard J, Nielson O. The role of tissue environmental factors on the kinetics and morphology of tumor cells exposed to hyperthermia. Ann New York Acad Sci 1980; 335: 254–280
   PubMedGoogle Scholar
• Westra A, Dewey WC. Variation in sensitivity to heat shock during the cell-cycle of chinese hamster cells in vitro. Int J Radiat Biol Realt Stud Phys Chem Med 1971; 9(5)467–477
   Google Scholar
• Lepock JR. Cellular effects of hyperthermia: Relevance to the minimum dose for thermal damage. Int J Hyperthermia 2003; 9(3)252–266
   Web of Science ®Google Scholar
• Lepock J. Protein denaturation during heat shock. Adv Molec Cell Biol 1997; 19: 223–259
   Google Scholar
• Wong R, Kapp L, Dewey W. DNA fork displacement rate meaasurements in heated Chinese hamster ovary cells. Biochim Biophys Acta 1989; 1007: 224–228
   PubMed Web of Science ®Google Scholar
• Wong R, Thompson L, Dewey W. Recovery from effects of heat on DNA synthesis in Chinese hamster ovary cells. Radiat Res 1988; 114: 125–137
   PubMed Web of Science ®Google Scholar
• Warters R, Lyons B. Inhibition of replicon cluster ligation into chromosomal DNA at elevated temperatures. J Cell Physiol 1990; 142: 365–372
   PubMed Web of Science ®Google Scholar
• Zuo J, Rungger D, Voellmy R. Multiple layers of regulation of human heat shock transcription factor 1. Mol Cell Biol 1995; 15: 4309–4331
   PubMed Web of Science ®Google Scholar
• Multhoff G, et al. A stress-inducible 72-kDa heat-shock protein (HSP72) is expressed on the surface of human tumor cells, but not on normal cells. Int J Cancer 1995; 61(2)272–279
   PubMed Web of Science ®Google Scholar
• Giovanella B, et al. Hyperthermic treatment of human tumors heterotransplanted in nude mice. Cancer Res 1979; 39: 2236–2241
   PubMed Web of Science ®Google Scholar
• Pelz J, et al. Histologic response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion. BMC Cancer 2006; 6(162)
   PubMed Web of Science ®Google Scholar
• Abdel-Wahab OI, et al. The role of hyperthermia in regional alkylating agent chemotherapy. Clin Cancer Res 2004; 10(17)5919–5929
   PubMed Web of Science ®Google Scholar
• Ko SH, et al. Optimizing a novel regional chemotherapeutic agent against melanoma: Hyperthermia-induced enhancement of temozolomide cytotoxicity. Clin Cancer Res 2006; 12(1)289–297
   PubMed Web of Science ®Google Scholar
• Brucker C, Sieg P. [Effect of combined carboplatin and ifosfamide with local hyperthermia on human mouth carcinoma in the animal model]. Mund Kiefer Gesichtschir 1999; 3((Suppl 1)S144–146
   PubMedGoogle Scholar
• Ferron G, et al. Feasibility of laparoscopic peritonectomy followed by intra-peritoneal chemohyperthermia: An experimental study. Gynecol Oncol 2005; 99(2)358–361
   PubMed Web of Science ®Google Scholar
• Lang H, et al. A porcine model for investigation of hyperthermic isolated liver perfusion. J Invest Surg 1998; 11(6)401–408
   PubMed Web of Science ®Google Scholar
• Johannsen M, et al. Thermotherapy using magnetic nanoparticles combined with external radiation in an orthotopic rat model of prostate cancer. Prostate 2006; 66(1)97–104
   PubMed Web of Science ®Google Scholar
• Myerson RJ, et al. Simultaneous superficial hyperthermia and external radiotherapy: report of thermal dosimetry and tolerance to treatment. Int J Hyperthermia 1999; 5(4)251–266
   Google Scholar
• Oleson JR, et al. Regional hyperthermia by magnetic induction in a beagle dog model: Analysis of thermal dosimetry. Radiat Res 1984; 98(3)445–455
   PubMed Web of Science ®Google Scholar
• Zakris EL, et al. Pharmacokinetics and toxicity of intraperitoneal cisplatin combined with regional hyperthermia. J Clin Oncol 1987; 5(10)1613–1620
   PubMed Web of Science ®Google Scholar
• Clary BM, et al. Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: Review of a large single-institutional experience with an emphasis on recurrence. Ann Surg 2001; 233(2)250–258
   PubMed Web of Science ®Google Scholar
• Jones E, Marks L, Prosnitz L. Point: Hyperthermia with radiation for chest wall recurrences. J Nat Comp Cancer Network 2007; 5(3)339–344
   PubMedGoogle Scholar
• Jones EL, et al. Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol 2005; 23(13)3079–3085
   PubMed Web of Science ®Google Scholar
• Mirimanoff R-O, et al. Radiotherapy and temozolomide for newly diagnosed glioblastoma: Recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 Phase III randomized trial. J Clin Oncol 2006; 24(16)2563–2569
   PubMed Web of Science ®Google Scholar
• Wagner W, et al. Survival rates of patients with glioblastoma multiforme treated with combined radiochemotherapy at first line. J Clin Oncol (Meeting Abstracts) 2005; 23(16Suppl.)1576
   Google Scholar
• Selker RG, et al. The Brain Tumor Cooperative Group NIH Trial 87-01: A randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine. Neurosurg 2002; 51(2)343–355, discussion 355–357
   PubMed Web of Science ®Google Scholar
• Emami B, et al. Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors: A prospectively controlled randomized study by the radiation therapy oncology group. Int J Radiat Oncol Biol Physics 1996; 34(5)1097–1104
   PubMed Web of Science ®Google Scholar
• Uzuka T, Takahashi H, Tanaka R. Interstitial hyperthermia with intra-arterial injection of adriamycin for malignant glioma. Neurol Med Chir (Tokyo) 2006; 46(1)19–23, discussion 23
   PubMed Web of Science ®Google Scholar
• Cummings B, Kim J, O'Sullivan B. Radiation therapy and managment of the cervical lymph nodes. Cummings B, Otolaryngology: Head and neck surgery4th. Mosby, Inc. 2005; 2589–2613
   Google Scholar
• Yoo C, et al. Recurrence following curative resection for gastric carcinoma. Brit J Surg 2000; 87(2)236–242
   PubMed Web of Science ®Google Scholar
• Roviello F, et al. Prospective study of peritoneal recurrence after curative surgery for gastric cancer. Brit J Surg 2003; 90(9)1113–1119
   PubMed Web of Science ®Google Scholar
• Macdonald JS, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001; 345(10)725–730
   PubMed Web of Science ®Google Scholar
• Keys HM, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999; 340(15)1154–1161
   PubMed Web of Science ®Google Scholar
• Morris M, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999; 340(15)1137–1143
   PubMed Web of Science ®Google Scholar
• Abstracts presented for the thirtieth annual meeting of the Society of Gynecologic Oncologists. Gynecol Oncol 1999; 72(3)443
   PubMed Web of Science ®Google Scholar
• Rose PG, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999; 340(15)1144–1153
   PubMed Web of Science ®Google Scholar
• Whitney CW, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999; 17(5)1339–1348
   PubMed Web of Science ®Google Scholar
• Dahl O, Mella O. Referee: Hyperthermia alone or combined with cisplatin in addition to radiotherapy for advanced uterine cervical cancer. Int J Hyperthermia 2002; 8(1)25
   Web of Science ®Google Scholar
• Cannistra SA. Cancer of the Ovary. N Engl J Med 1993; 329(21)1550–1559
   PubMed Web of Science ®Google Scholar
• Ryu KS, et al. Effects of intraperitoneal hyperthermic chemotherapy in ovarian cancer. Gynecol Oncol 2004; 4(2)325–332
   Web of Science ®Google Scholar
• Bae J, et al. Treatment of ovarian cancer with paclitaxil- or carboplatin-based intraperitoneal hyperthermic chemotherapy during secondary surgery. Gynecol Oncol 2007; 106: 193–200
   PubMed Web of Science ®Google Scholar
• Gori J, et al. Intraperitoneal hyperthermic chemotherapy in ovarian cancer. Int J Gynecol Cancer 2005; 5(2)233–239
   Google Scholar
• Sugarbaker P. Colorectal carcinomatosis: A new oncologic frontier. Current Opin Oncol 2005; 17(4)397–399
   PubMed Web of Science ®Google Scholar
• Verwaal V, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003; 21(20)3737–3743
   PubMed Web of Science ®Google Scholar
• Smeenk RM, Verwaal VJ, Zoetmulder FA. Pseudomyxoma peritonei. Cancer Treat Rev 2007; 33(2)138–145
   PubMed Web of Science ®Google Scholar
• Loungnarath R, et al. Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: A prospective study. Dis Colon Rectum 2005; 48(7)1372–1379
   PubMed Web of Science ®Google Scholar
• Guner Z, et al. Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei. Int J Colorectal Dis 2005; 20(2)155–160
   PubMed Web of Science ®Google Scholar